A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2-Reference-Cited by-同舟云学术

A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2

Published:2016-04-20 Issue:13 Volume:76 Page:3838-3850
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Yang Shouhui,He Peijun,Wang Jian,Schetter Aaron,Tang Wei,Funamizu Naotake,Yanaga Katsuhiko,Uwagawa Tadashi,Satoskar Abhay R.,Gaedcke Jochen,Bernhardt Markus,Ghadimi B. Michael,Gaida Matthias M.,Bergmann Frank,Werner Jens,Ried Thomas,Hanna Nader,Alexander H. Richard,Hussain S. Perwez

Funder

Intramural Research Program of the Center for Cancer Research, NCI, NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and model construction of survival-associated proteins for pancreatic cancer based on deep learning;Future Generation Computer Systems;2024-12

2. Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study;Pathology - Research and Practice;2024-10

3. NR3C2 affects the proliferation and invasiveness of colon cancer cells through the Wnt/β-Catenin signaling pathway;Journal of Cancer Research and Clinical Oncology;2024-09-05

4. The multifaceted role of the mineralocorticoid receptor in cancers;The Journal of Steroid Biochemistry and Molecular Biology;2024-09

5. Potential impact of epithelial splicing regulatory protein 1 (ESRP1) associated with tumor immunity in pancreatic adenocarcinoma;Journal of Proteomics;2024-09